I'd say this supplementary prospectus is due to the ASX believing they didn't fully disclose the risks via previous updates.
That or their legal counsel said that they'd be open to a class action.
Company looks like quite the basket case, but the Painaway acquisition could have merit, though they could well have overpaid.
Painaway is a good brand in the right hands. Time will tell if these are the right hands.
Ann: Supplementary Prospectus, page-3
Add WNX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $34.81M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.7¢ | $19.85K | 735.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1309232 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 47791 | 1 |
View Market Depth
| Last trade - 13.32pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.7¢ |
Change
-0.001 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 2.7¢ | 2.7¢ | 2.6¢ | 294112 | ||
| Last updated 13.50pm 06/06/2024 ? | |||||
| WNX (ASX) Chart |